2nd Quarter - Report

SAFEWAY INC. for SAFEWAY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2021 $90,000 Replaced
2nd Quarter - Termination Jul 27, 2021 $90,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

S 1260 - United States Innovation and Competition Act of 2021, provisions related to country of origin labeling for agriculture products

LobbyistCovered position, as disclosed
KATE COLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

S. 1909 and H.R. 3554 - Pharmacy DIR Reform to Reduce Senior Drug Costs Act

LobbyistCovered position, as disclosed
KATE COLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1909 (117th), H.R. 3554 (117th)

Labor Issues/Antitrust/Workplace LBR

H.R. 5, The Equality Act - all provisions P.L. 117-2, The American Rescue Plan Act of 2021 - provisions related to multiemployer pension plans

LobbyistCovered position, as disclosed
KATE COLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.